Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma. [electronic resource]
Producer: 20180326Description: 1247-1257 p. digitalISSN:- 1592-8721
- Antineoplastic Agents -- pharmacology
- Biomarkers
- Burkitt Lymphoma -- drug therapy
- Cell Death -- drug effects
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Electron Transport Complex I -- antagonists & inhibitors
- Energy Metabolism -- drug effects
- Humans
- Lactic Acid -- metabolism
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Mitochondria -- drug effects
- Monocarboxylic Acid Transporters -- antagonists & inhibitors
- Muscle Proteins -- genetics
- Oxidative Phosphorylation -- drug effects
- Pyrimidinones -- pharmacology
- Symporters -- antagonists & inhibitors
- Thiophenes -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.